RIGEVIDON

Medicinal product

(Invented) name

RIGEVIDON

Active substance (s)

Etinilestradiolis/Levonorgestrelis

Strength

30 µg/150 µg

Pharmaceutical form

dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

G03AA07, Levonorgestrel and ethinylestradiol

Marketing authorisation holder

Gedeon Richter Plc, Vengrija

Date of authorisation

2000-07-04

Date of renewal

2008-01-17

Documents

0985 Pakuotės lapelis 2022 08 30.docx

0985 RIGEVIDON PCS PL 2022 08 30.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Etinilestradiolis	30 µg
Levonorgestrelis	150 µg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
7348	12317	1012317	lizdinė plokštelė	N21		Receptinis	LT/1/2000/0985/001	Tiekiama	-	-	No	-	-
7349	12318	1012318	lizdinė plokštelė	N3x21		Receptinis	LT/1/2000/0985/002	Tiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2008-01-17	Perregistruotas
2000-07-04	Registruotas